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All rigObjective. The aim of this study was to review the results of carotid endarterectomy (CEA) at the Royal Brisbane and
Women’s Hospital (RBWH) to provide a benchmark for comparison with carotid stenting and to document changes in
imaging and procedural techniques over time.
Methods. Analysis of RBWH CEA database from 1992 to 2007.
Results. 1313 consecutive patients (average age 69.2 years, 9% 80 years or older, 69% males) underwent carotid endar-
terectomy at the RBWH between 1992 and May 2007. Indication for surgery was symptomatic disease in 67%. Preoper-
ative investigations included a duplex scan in 97%, an angiogram in 24% and a CT brain in 33%. Angiogram related
neurological events occurred in 3.5% of patients (1.6% stroke, 1.9% TIA). There were 7 deaths (0.5%) and 28 strokes
(2.1%) for a combined stroke and death rate of 2.4%. The rate of transient ischemic attacks was 1.1%. Gender patch
use and trainees operating with the surgeon unscrubbed predicted a higher combined stroke and death rate. Trends over
time included: reduction in preoperative angiography from 66% to <5% and increased rate of patching from 39% to
approximately 100%.
Conclusions. Performance of CEA at the RBWH is in keeping with published literature standards. There has been an
evolution to surgery performed on the basis of duplex ultrasound alone and an almost universal use of patching.
Crown Copyright  2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All rights
reserved.
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Carotid endarterectomy (CEA) remains the gold stan-
dard intervention for carotid artery stenosis to which
newer technologies must be compared. Its superiority
to medical management in severe and symptomatic
carotid artery disease has been well demonstrated
by several large randomized trials.1e5 The role of
endovascular therapies and surgery continues to be
actively debated and many trials are ongoing.6
Every vascular surgery group will need to closely
monitor their results during these times to facilitate
a safe introduction of newer technologies and to gives from 1989 to 2004 presented at the ANZSVS 2004, Rotorua,
Zealand and abstract of meeting published in ANZ
74(9); A148.
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hts reserved.their patients an informed choice between them. Accu-
rate audit provides insight into a group’s performance,
possible areas of improvement and changes in practice
that can be compared to the published literature and to
results of newer technologies.
The aims of this study were to review the results of
carotid endarterectomy at the Royal Brisbane and
Women’s Hospital (RBWH) over a 15 year period
from 1992e2007, to identify changes in the practice
of carotid endarterectomy over this time period, to
provide a benchmark for future comparison with
our carotid stenting results and to compare the results
to Australian and international experience.Method
The audit was compiled from data collected on all pa-
tients that had a carotid endarterectomy from 1992
until May 2007. Data was collected prospectively. In-
formation was collected by medical staff on a carotidby Elsevier Ltd on behalf of European Society for Vascular Surgery.
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274 N. Organ et al.endarterectomy data sheet with the data transferred
to an SPSS database for analysis.
Chi square, Fisher’s exact, unpaired student t tests
and Mann-Whitney U test were used where appropri-
ate. Statistical analysis was performed using SPSS
for Windows (SPSS Inc., Chicago) and Statview
5.0.1 (SAS Institute, Cary, NC). A p value less than
0.05 was considered statistically significant.0
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Fig. 1. Decline in number of endarterectomies performed
and a decline in surgery for asymptomatic stenosis (Chi
square 0.0007).Results
There were 1313 carotid endarterectomies performed
from 1992 to May 2007. The average patient age was
69.2 years with 9% aged over 80 years. There was
no change in age distribution over the 15 years. 69%
of patients were male and this has slowly increased
from 56% in 1992 to 80% in 2007. The distribution
of cardiovascular and carotid endarterectomy risk
factors were as expected (Table 1).
The number of carotid endarterectomies performed
peaked in 1997 at 131 and has declined recently to ap-
proximately 60 per year (Fig. 1). 67% of carotid endar-
terectomies were done for symptomatic disease.
Indications were stroke (16%), transient ischaemic at-
tacks (30%), amaurosis fugax (15%) and non hemi-
spheric symptoms (6%). Surgery for asymptomatic
stenosis has declined since 1992 (Fig. 1). CEA per-
formed with CABG is offered at an affiliated hospital
and these patients have been recorded on a separate
database and are excluded from this analysis.
There has been a gradual reduction in the use of
angiography for preoperative imaging from 66% in
1992 to only 5% in the last 4 years. Overall 97% of
patients in the study group had a preoperative duplex
ultrasound and 24% underwent angiography (Fig. 2).
33% of patients underwent preoperative cerebral CT
scanning.
The consultant surgeon was the recorded primary
operator in 63% of the cases. Shunts were used in
42% of cases. Shunt indication and use varied accord-
ing to individual surgeon preference. There was noTable 1. Patient risk factors
Risk factor Percent
Smoking (22% active, 62% reformed) 84%
Hypertension 70%
Diabetes 19%
Hypercholesterolaemia 42%
IHD (265% angina, 18% MI, 19% CABG) 51%
Respiratory disease 11%
Contralateral disease 43%
(23% moderate, 10% severe, 9% occluded)
3 or more risk factors 36%
Redo surgery 2.2%
Eur J Vasc Endovasc Surg Vol 35, March 2008difference in shunt use if the primary operator was
surgeon or trainee. Stump pressures were recorded
in 30% and a patch was used in 82% of endarterecto-
mies. 60% of the patches were vein, most often ankle
vein. Clamp time when recorded averaged 26 mins.
General anaesthesia and a wound drain were used
almost exclusively with only 8 patients operated on
under local anaesthesia.
Over the 15 years there has been a general decline
in shunt use, an increase in patch closure of the arte-
riotomy and a trend towards the use of synthetic
patches (Figs. 3 and 4).
The overall stroke and death rate for the 15 years
was 2.5% (symptomatic 2.4%, asymptomatic 3.4%).
This consisted of 28 strokes and 7 deaths. Stroke was
defined as any neurological deficit lasting > 24 hours.
There was no differentiation between major and minor
strokes in the database. Three deaths were after severe
strokes, three from an intracranial (hyperperfusion)
bleed and two from vein patch rupture (ankle LSV).
If this is combined with the angiogram related strokes
the stroke and death rate becomes 2.8%. There were no
angiogram related deaths. There were 14 TIA’s in the
post-operative period (1.1%). There were also two
non fatal hyperperfusion bleeds and 2 seizures. One
patient with a previously undiagnosed brain tumour
developed edema and associated symptoms during
the post operative period. Minor symptoms such as
headache that may be due to hyperperfusion were
not recorded on the database.
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Fig. 2. Preoperative investigations. Decline in angiography (Chi square P< 0.0001) and increase in use of duplex alone (Chi
square P< 0.0001).
27515 Years of Carotid Endarterectomy in a Teaching HospitalComplications are summarised in Table 2. The av-
erage length of stay was 3.9 days post operatively.
The post operative length of stay has decreased
from 4 to 3 days and the total length of stay has de-
clined from 7 to 4 days (unpaired t test, p< 0.001).0
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Fig. 3. Increase in patching over time (Chi square p< 0.0001)
and decrease in shunting (Chi square¼ 0.01)A return to theatre had a higher morbidity and
mortality (Table 3). This increased risk occurred in
the patients that returned to theatre for neurological
symptoms rather than those that returned for bleed-
ing. Those that returned to theatre were less likely
to have a patch closure. Of those with patch closure
2.1% returned to theatre compared to those with pri-
mary closure where 4.7% returned to theatre (Fisher’s
exact P¼ 0.04).
The combined angiographic and surgical stroke
and death rate was higher in those patients that un-
derwent angiography (5.5%) compared to those that
were operated on after duplex ultrasonography alone
(1.8%) (Fisher’s exact P¼ 0.002). There was an in-
crease in the rate of stroke and death in the group
that were not patched, in females and when the sur-
geon was unscrubbed and the trainee was the primary
surgeon (Table 4). Though not statistically significant
there was a decline in the combined stroke and death
rate from 3.9% in the five year block from 1992e6
down to 1.9% in the last five years.
Those patients that suffered a stroke complicating
their CEA had a higher mortality (10% vs 0.3%),
length of stay (17 vs 5 days), need for ICU admission
(16% vs 2.3%) and return to theatre (29% vs 2%)Eur J Vasc Endovasc Surg Vol 35, March 2008
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Fig. 4. Change in use of patch type over time showing an increase in the use of synthetic patches particularly the polyure-
thane patch (Chi square P< 0.0001).
276 N. Organ et al.(Fishers exact or Mann Whitney U P< 0.0001). The
only risk factors associated with a greater mortality
were stroke, myocardial infarction and return to the-
atre for neurological symptoms. Return to theatre for
bleeding was not associated with increased mortality.
Follow up duplex scan results were available for
65% of all patients. Follow up scans were available
for a mean of 40 weeks after the endarterectomy with
a range of 1e383 weeks. The restenosis rate was de-
fined as greater than 50% by University of WashingtonTable 2. Incidence of perioperative complications
Complication Percent
Death 0.5%
CVA 2.1%
TIA 1.1%
Return to theatre
e bleeding 2.0%
e neurological deficit 0.6%
Myocardial infarction 1.2%
Wound infection 0.7%
CN injury(temporaryþ permanent) 1.6%
e (X 30%, XI 9%, XII 61%)
ICU admission 4%
Vein patch blow out 0.2%
Hyperperfusion events (major) 0.6%
e bleeding 0.4%, seizure 0.2%, edema of
brain tumour 0.1%
Eur J Vasc Endovasc Surg Vol 35, March 2008Doppler velocity criteria. The rate of restenosis was
3.2%. There was no difference in restenosis rate if
a patch was used.Discussion
Carotid endarterectomy is performed at many large
centres in Australia, New Zealand and internationally
in a group of patients with similar demographics.7e12
In this series there was a steady increase in the per-
centage of male patients treated from 56% of patients
in 1992 to 80% in 2007. This may be influenced by the
documented better outcomes for males compared to
females as reported in the ACAS and ACST trial.4,5
However only 33% of patients in our series were
asymptomatic. There was a better outcome in malesTable 3. Effect of return to theatre on incidence of stroke, ICU
admission rate and mortality. (Fisher’s exact P< 0.001 for all
three variables)
Event Return to theatre
(n¼ 34)
Did not return to theatre
(n¼ 1279)
Stroke 23% 1.6%
ICU admission 16% 2.5%
Mortality 6% 0.4%
Table 4. Effect of common risk factors for carotid endarterectomy
on perioperative stroke and death rate
Factor Description Perioperative
CVA/Death
P (Fisher’s or
Chi square)
Sex Male 1.9% P¼ 0.05
Female 3.6%
Age <80 2.7% P¼ 0.08
>80 0
Symptomatic
status
Symptomatic 2.4% P¼ 0.78
Asymptomatic 2.7%
Number of
risk factors
Less than 3 2.9% P¼ 0.16
3 or more 1.6%
>80% contralateral
ICA stenosis
or occlusion
Present 1.9% P¼ 0.54
Absent 2.3%
Reoperation Yes 6.6% P¼ 0.13
No 3.9%
Operator Surgeon 2.3% P¼ 0.6
Trainee 2.7%
Operator and
level of trainee
supervision
Consultant Trainee
with consultant
scrubbed Trainee
with consultant
unscrubbed
2.3% P¼ 0.025
2.4%
3.7%
Shunt Yes 2.3% P¼ 0.82
No 2.5%
Patch Use Patch 1.9% P¼ 0.003
No Patch 5.2%
Patch type Synthetic 1.2% P¼ 0.12
Vein 2.4%
27715 Years of Carotid Endarterectomy in a Teaching Hospitalin our patient group. Others have not demonstrated
a difference.13
The number of carotid endarterectomies performed
per annum increased until 1997 and then the number
slowly decreased. This is similar to published popula-
tion based trends seen in Australia and the USA.14,15
The rise in the early to middle 1990’s is attributed to
the results of the NASCET and ECST trials published
in 1991 and the ACAS results published in 1995.2e4
Many reasons are postulated by others for the down-
ward trend after 1998 including the treatment of all
prevalent cases and better medical management of
atherosclerotic disease.14 In our series it is also proba-
bly a reflection of reduction in private cases because of
bed shortages and a more conservative approach to
asymptomatic disease.
As in most recent publications perioperative angi-
ography is now used in <10% of patients. Duplex
ultrasound has consistently been shown to be a safe
alternative to angiography as the sole modality for
preoperative imaging with angiography being re-
served for atypical cases.10,16
In a supervised position vascular surgical trainees
perform carotid endarterectomy with similar results
to the consultant surgeon. This has previously been
reported by Mayer et al. St Vincent’s Hospital, Mel-
bourne.8 These findings may be influenced by careful
case selection and supervision of the trainees by the
consultant surgeon. However when the surgeon wasunscrubbed and the trainee was the primary operator
(108 cases) the event rate was higher (Table 4).
Other trends over time are in keeping with other
published series including a reduction in ICU use,
length of stay and shunting and an increase in patient
age, other comorbidities and in patch closure of the
arteriotomy.10,16,17 As in these other series there has
been no increase in adverse events as a result of these
changes and it likely that some have resulted in signif-
icant cost savings.
The most recent Cochrane review reflects current
controversy on the effect of patch closure on the inci-
dence of perioperative thrombosis and late resteno-
sis.18 In this series with univariate analysis primary
closure was associated with a higher stroke rate and
a higher rate of return to theatre but there was no
effect on rate of late restenosis.
The increase in use of synthetic patches is probably
due to good results with their use and surgeon con-
cern about a small rate of vein patch disruptions.
The best type of patch continues to be debated in
the literature.19e22 Vein patch avoids the small risk
of infection of prosthetic material, is cheaper and
may reduce the incidence of restenosis. The risk of
vein use includes a possible second wound either in
the groin or ankle as well as a risk of early patch rup-
ture or late pseudoaneurysm formation.19 This series
had no incidence of patch infections and no pseudoa-
neurysm formation but 3 vein patch disruptions two
of which were fatal. There was no record of internal
carotid size and the decision to patch is an individual
surgeon choice in our unit.
The use of shunting and its selection continues to
be controversial. In our unit the technique of shunting
and choice of shunt vary between surgeons. Selection
may depend on symptoms, contralateral disease,
stump pressures or backflow. Most surgeons report
a decline in their personal shunt use.
The results for stroke rate and mortality are similar
to other large case series and our results compare fa-
vourably with major published trials and guidelines
including Cochrane and the American Heart Associa-
tion guidelines.23e25
The myocardial infarction rate in our RBWH series
was very low (1.2%) however serial ECGs and cardiac
enzymes were not performed routinely, almost cer-
tainly underestimating the true cardiac event rate. Jor-
dan et al. found that cardiac events tended to be higher
in a high risk group of patients undergoing carotid
endarterectomy (3.1% myocardial infarction rate in
high risk patients versus 1% in low risk, Fisher’s exact
P¼ 0.15).26 On going improvements in perioperative
risk factor modification, anaesthetic techniques and
use of local anesthesia may have an effect on this rate.Eur J Vasc Endovasc Surg Vol 35, March 2008
278 N. Organ et al.Patients that required a return to theatre for neuro-
logical symptoms had a high rate of ICU admission
and a higher mortality. Stewart et al. reviewed 25 pa-
tients that returned to theatre for neurological events
and compared their outcome to 26 that had a neuro-
logical event but did not return to theatre. Re-explora-
tion of the carotid artery, even if pathology was found,
did not improve clinical outcome.27
Analysis of this case series did not reveal a high
risk group of patients, even when selecting those
with a combination of symptomatic disease, physio-
logical risk factors and contralateral disease. This
may be a type II error due to the small number of
events but also reflects the difficulty in defining
a high risk group in a centre with good results for
morbidity and mortality after carotid endarterectomy.
Others have also had difficulty defining this en-
tity.11,12,28,29 Ouriel et al. were able to identify a high
risk group by being very specific about the severity
of risk factors, not just their presence however 67%
of their patients underwent combined CEA-CABG.30
Octogenarians and SAPPHIRE eligible patients have
also undergone carotid endarterectomy with no
greater risk of stroke or death.31,32 Perhaps a scoring
system using grading of physiological and surgical
or anatomic risk factors will help resolve this in the
future.33,34
Short stay for carotid endarterectomy with an over-
night admission can be achieved with no detriment in
outcome.10,16,35e37 The length of stay in this series was
longer than many published series. This reflects both
the patient population treated as well as the method
of calculating length of stay. The patients treated at
the Royal Brisbane and Women’s Hospital come
from a large geographic area and can face transport
distances of 400 km or greater to return to their place
of residence. Many of these patients have no form of
personal transport so discharge is delayed whilst
awaiting suitable transport. Until recently intrave-
nous heparin therapy was the perioperative warfarin
replacement treatment of choice for patients with
prosthetic cardiac valves. Low molecular weight hep-
arin is now used in the community setting, reducing
hospital admission time. The length of stay also in-
cludes any time spent in a neurological ward before
acute endarterectomy for symptomatic disease as
well as any time spent in rehabilitation after surgery.
Thus the length of stay does not just reflect the time
spent in the acute vascular ward.
One of the disadvantages of carotid endarterec-
tomy over carotid stenting is the incidence of cranial
nerve injury. Our group has a low incidence of cranial
nerve palsy (1.6%). The absence of neurologist assess-
ment suggests that the real incidence may be higher.Eur J Vasc Endovasc Surg Vol 35, March 2008Marginal mandibular nerve injuries are not included
in the database.
This study has several limitations including hetero-
geneity of data collectors and neurological assessment
by the surgical team and not an independent neurolo-
gist. The low incidence of adverse events and the low
prevalence of some risk factors limit statistical analy-
sis. In 1996 Rothwell et al. performed a systematic
review of mortality and risk of stroke after carotid end-
arterectomy for symptomatic disease. The risk of
stroke was related to the authorship of the study, being
highest when there was a neurologist assessment and
lowest with a single surgeon or author. A study such
as this one, reported by a group of authors affiliated
with a Department of Surgery, faired in-between.38Conclusion
Carotid endarterectomy at the Royal Brisbane and
Women’s Hospital is performed with results that com-
pare favorably with those of the larger published
trials and in keeping with international trends and
guidelines. This includes a trend towards duplex ul-
trasound as the sole preoperative imaging modality,
a decline in the number of female patients undergoing
CEA, a decline in intraoperative shunting an increase
to almost routine patching for vessel closure and
a change to synthetic patches as the preferred patch.
High risk patients who could confidently be offered
alternative treatments such as endovascular therapies
remain difficult to define by simple methods.
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